3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Carcinoma, Non-Small-Cell Lung
13
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma
11
Hodgkin Disease
11
Lymphoma, Non-Hodgkin
10
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Mantle-Cell
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Burkitt Lymphoma
7
Breast Neoplasms
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Blast Crisis
6
Sezary Syndrome
5
Prostatic Neoplasms
5
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Mycosis Fungoides
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, Extranodal NK-T-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Brain Neoplasms
5
Interventions
Cyclophosphamide
9
Topotecan
5
Temozolomide
5
Melphalan
5
Irinotecan
5
Busulfan
5
fludarabine
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
liposomal doxorubicin
3
fludarabine phosphate
3
cabozantinib
3
Vincristine
3
regorafenib
2
pegfilgrastim
2
Sirolimus
2
Doxorubicin
2
Bone Marrow Transplantation
2
trioctyl phosphine oxide
1
trifluridine tipiracil drug combination
1
thymoglobulin
1
talazoparib
1
selinexor
1
seclidemstat
1
racotumomab
1
poly ICLC
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
olaparib
1
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sarcoma, Ewing
×
Vorinostat
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled